These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37445233)

  • 1. Prevalence and Characteristics of Itch and Pain in Patients Suffering from Chronic Hand Eczema.
    Zalewski A; Krajewski PK; Szepietowski JC
    J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of Existing and New Treatments for the Management of Hand Eczema.
    Ho JSS; Molin S
    J Cutan Med Surg; 2023; 27(5):493-503. PubMed ID: 37496489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core patient-reported outcome measures for chronic pain patients treated with spinal cord stimulation or dorsal root ganglia stimulation.
    Huygen F; Hagedorn JM; Falowski S; Schultz D; Vesper J; Heros RD; Patterson DG; Dehghan S; Ross E; Kyani A; Mansouri MB; Kallewaard JW
    Health Qual Life Outcomes; 2023 Jul; 21(1):77. PubMed ID: 37474950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial.
    Guttman-Yassky E; Silverberg JI; Thaçi D; Papp KA; Ständer S; Beck LA; Kim BS; Hu X; Liu J; Calimlim BM; Vigna N; Crowley JT; Teixeira HD; Thyssen JP
    J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):2558-2568. PubMed ID: 37528500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diseases from the Spectrum of Dermatitis and Eczema: Can "Omics" Sciences Help with Better Systematics and More Accurate Differential Diagnosis?
    Spiewak R
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and Future Trends in Atopic Dermatitis.
    Gatmaitan JG; Lee JH
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pruritus burden assessment in severe atopic dermatitis patients under dupilumab: response predictor?
    Brás R; Limão R; Pedro E; Lopes A
    Eur Ann Allergy Clin Immunol; 2023 Jul; ():. PubMed ID: 37503751
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer Patients with Chronic Pain and Their Caregivers during COVID-19: A Descriptive Study.
    Costeira C; Paiva-Santos F; Pais N; Sousa AF; Paiva I; Carvalho DH; Rocha A; Ventura F
    Nurs Rep; 2023 Jun; 13(3):934-945. PubMed ID: 37489404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study.
    Pezzolo E; Schena D; Gambardella A; Rossi M; Barei F; Calzavara Pinton P; Girolomoni G; Naldi L; Ferrucci SM
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e11-e13. PubMed ID: 37483150
    [No Abstract]   [Full Text] [Related]  

  • 10. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs.
    Kolkhir P; Akdis CA; Akdis M; Bachert C; Bieber T; Canonica GW; Guttman-Yassky E; Metz M; Mullol J; Palomares O; Renz H; Ständer S; Zuberbier T; Maurer M
    Nat Rev Drug Discov; 2023 Sep; 22(9):743-767. PubMed ID: 37528191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tralokinumab in the treatment of atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials.
    Zhao DJ; Huang LM; Xiao J; Chen L; Li X; Lin HX
    Medicine (Baltimore); 2023 Aug; 102(31):e34516. PubMed ID: 37543792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of skin atrophy induced by short-term topical corticosteroid use in atopic dermatitis lesional skin: A systematic review.
    Ricardo JW; Gosch M; Wang Y; Wright DN; Jorizzo J
    JAAD Int; 2023 Sep; 12():165-167. PubMed ID: 37456622
    [No Abstract]   [Full Text] [Related]  

  • 13. Tralokinumab therapy for moderate-to-severe atopic dermatitis: Clinical outcomes with targeted IL-13 inhibition.
    Simpson EL; Guttman-Yassky E; Eichenfield LF; Boguniewicz M; Bieber T; Schneider S; Guana A; Silverberg JI
    Allergy; 2023 Nov; 78(11):2875-2891. PubMed ID: 37455359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies.
    Stein Gold L; Pinter A; Armstrong A; Augustin M; Arenberger P; Bhatia N; Praestegaard M; Iversen L; Reich A
    Dermatol Ther (Heidelb); 2023 Sep; 13(9):2031-2044. PubMed ID: 37490268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the chronic pain journey and coping strategies that patients use to manage their chronic pain: a qualitative, patient-led, Canadian study.
    Bruce M; Lopatina E; Hodge J; Moffat K; Khan S; Pyle P; Kashuba S; Wasylak T; Santana MJ
    BMJ Open; 2023 Jul; 13(7):e072048. PubMed ID: 37491089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of tofacitinib in baricitinib-refractory atopic dermatitis: An example of JAK inhibitor switching.
    Dhir B; Meena SK; Sardana K; Sharath S
    Pediatr Dermatol; 2024; 41(1):139-140. PubMed ID: 37495552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real World Clinical Utility of Neurophysiological Measurement Utilizing Closed-Loop Spinal Cord Stimulation in a Chronic Pain Population: The ECAP Study Protocol.
    Leitner A; Hanson E; Soliday N; Staats P; Levy R; Pope J; Kallewaard JW; Doleys D; Li S; Weisbein J; Amirdelfan K; Poree L
    J Pain Res; 2023; 16():2497-2507. PubMed ID: 37497371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difelikefalin suppresses itch and reduces scratching independent of inflammation in a murine model of atopic dermatitis.
    Tamari M; Zamidar L; Ver Heul AM; Nograles K; Goncalves J; Guttman-Yassky E; Lebwohl M; Kim BS
    J Allergy Clin Immunol; 2023 Oct; 152(4):927-932. PubMed ID: 37453613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota and IL-33/31 Axis Linkage: Implications and Therapeutic Perspectives in Atopic Dermatitis and Psoriasis.
    Bonzano L; Borgia F; Casella R; Miniello A; Nettis E; Gangemi S
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atopic Dermatitis: A Common Pediatric Diagnosis That Is Not Just Another Rash.
    Gooch MD; Jordan KS
    Adv Emerg Nurs J; 2023 Jul-Sep 01; 45(3):195-205. PubMed ID: 37501270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.